BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20656273)

  • 1. [Predictive value of the asymptomatic prostatic inflammation in the development of prostate cancer].
    Molimard B; Camparo P; Desfemmes FR; Durand X; Haus R; Deligne E; Houlgatte A; Compérat E
    Prog Urol; 2010 Jul; 20(7):508-14. PubMed ID: 20656273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
    Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
    Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
    Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M
    Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies.
    Gallo F; Chiono L; Gastaldi E; Venturino E; Giberti C
    Urology; 2008 Sep; 72(3):628-32. PubMed ID: 18279918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma.
    Netto GJ; Epstein JI
    Am J Surg Pathol; 2006 Sep; 30(9):1184-8. PubMed ID: 16931964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI; Herawi M
    J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.
    Moreira DM; Nickel JC; Gerber L; Muller RL; Andriole GL; Castro-Santamaria R; Freedland SJ
    Cancer; 2014 Jan; 120(2):190-6. PubMed ID: 24323568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies.
    Schröder FH; van den Bergh RC; Wolters T; van Leeuwen PJ; Bangma CH; van der Kwast TH; Roobol MJ
    Eur Urol; 2010 Feb; 57(2):256-66. PubMed ID: 19913350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can non-malignant biopsy features identify men at increased risk of biopsy-detectable prostate cancer at re-screening after 4 years?
    Wolters T; Roobol MJ; Schröder FH; van der Kwast TH; Roemeling S; van der Cruijsen-Koeter IW; Bangma CH; van Leenders GJ;
    BJU Int; 2008 Feb; 101(3):283-8. PubMed ID: 17922858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population.
    Steiner H; Moser P; Hager M; Berger AP; Klocker H; Spranger R; Rogatsch H; Bartsch G; Horninger W
    Prostate; 2004 Feb; 58(3):277-82. PubMed ID: 14743467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in prostate cancer.
    Stattin P
    Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer.
    Sutcliffe S; Giovannucci E; De Marzo AM; Leitzmann MF; Willett WC; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2160-6. PubMed ID: 17119041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.